Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina

American Journal of Cardiology

Volumn 82, Issue 4, 1998, Pages 515-518

  Gaspardone, Achille ^a   Crea, Filippo ^a   Versaci, Francesco ^a   Tomai, Fabrizio ^a   Pellegrino, Antonio ^a   Chiariello, Luigi ^a   Gioffrè, Pier A ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CREATINE KINASE; CREATINE KINASE MB; DILTIAZEM; TICLOPIDINE; TROPONIN I;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; STENT; TREATMENT OUTCOME;

ADULT; AGED; ANGINA PECTORIS; C-REACTIVE PROTEIN; CARDIAC SURGICAL PROCEDURES; CORONARY DISEASE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; STENTS;

EID: 0031848589     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00370-1     Document Type: Article

References (20)

1. Serruys PW, Emanuelsson H, van der Giessen W, Lunn AC, Kiemeney F, Macaya C, Rutsch W, Heyndrickx G, Suryapramata H, Legrand V, Goy JJ, Materne P, Bonnier H, Morice M, Fajadet J, Belardi J, Colombo A, Garcia E, Ruygrok P, de Jaegere P, Morel M, on behalf of the Benestent-II Study Group. Heparin-coated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent-II Pilot Study. Circulation 1996;93:412-422.
2. Hoffman R, Mintz GS, Dussailant GR, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996;94:1247-1254.
3. De Servi S, Mazzone A, Ricevuti G, Fioravanti A, Bramucci E, Angoli L, Ghio S, Specchia G. Granulocyte activation after coronary angioplasty in humans. Circulation 1990;82:140-146.
4. Pietersma A, Kofflard M, de Wit EA, Stijnen T, Koster JF, Serruys PW, Sluiter W. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation 1995;91:1320-1325.
5. Libby PS, Warmer JC, Friedman GB. Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest 1988;81:487-498.
6. Gauldie J, Richards C, harnish D, Lansdorp P, Baumann H. Interferon b2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 1987;84:7251-7255.
7. Pepys MB. C-reactive protein fifty years on. Lancet 1981;1:653-656.
8. Ryan TJ, Bauman WB, Kennedy JW, Kereiakes, King SB III, McAllister BD, Smith SC, Ullyot DJ. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 1993;12:2987-3005.
9. Hyafner G, Endler T, Oppitz M. Effects of standardization with the new international reference preparation for proteins in human serum on method comparability and reference values. Clin Lab 1995;41:743-748.
10. Berk BC, Weitraub WS, Alexander EW. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 1990;65:168-172.
11. de Beer FC, Hind CR, Fox KM, Allan RM, Maseri A, Pepys MB. Measurement of serum C-reactive protein concentration in myocardial ischemia and infarction. Br Heart J 1982;47:239-243.
12. Gaspardone A, Ciavolella M, Carlizzi G, Xagoraris V, Romeo F, Gioffrè PA. Determinazione della proteina C-reattiva in cardiochirurgia: importanza nel monitoraggio post-operaterio delle complicanze. Cardiologia 1982;27:1121-1132.
13. Liuzzo G, Biasucci LM, Gallimore RJ, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-424.
14. Pietila KO, Harmoinen AP, Jokiniitb A, Pasternack AI. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J 1996;17:1345-1349.
15. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635-641.
16. Kuller LH, Tracy RPO, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary hearth disease in the MRFIT nested case-control study. Am J Epidemiol 1996;144:537-547.
17. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979.
18. Gaspardone A, Perino M, Ghini AS, Ferri C, Desideri G, Tomai F, Versaci F, Iamele M, De Fazio A, Gioffrè PA. Effects of exercise-induced myocardial ischemia on C-reactive protein in chronic stable angina (abstr). Eur Heart J 1997;18(suppl):631.
19. Liuzzo G, Biasucci LM, Rebuzzi AG, Gallimore JR, Caligiuri G, Lanza GA, Quaranta G, Monaco C, Pepys MB, Maseri A. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation 1996;94:2373-2380.
20. Azar RR, Seecharran B, Feng YJ, Giri S, Wu AH, Kierman F, McKay R, Waters DD. Coronary angioplasty induces a systemic inflammatory respnse (abstr). Circulation 1996;94(suppl I):I-560.